4503 — Astellas Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual balance sheet for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	C2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	311,074	324,943	326,128	318,267	376,946
Net Total Accounts Receivable
Net Total Receivables	365,348	373,505	362,722	423,018	465,455
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	857,159	867,514	872,588	923,354	1,049,954
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	173,483	268,600	264,623	269,044	286,459
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,897,648	2,315,169	2,273,628	2,332,395	2,456,518
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	497,665	798,708	592,372	687,411	726,034
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	639,252	1,026,001	887,513	872,087	948,564
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,258,396	1,289,168	1,386,115	1,460,308	1,507,954
Total Liabilities & Shareholders' Equity	1,897,648	2,315,169	2,273,628	2,332,395	2,456,518
Total Common Shares Outstanding